Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction.
Diabetes is a common complication encountered during pregnancy. Earlier studies indicated that diabetic placentas bear morphological alterations consistent with modified placental differentiation, including alterations in the villous cellular content, structure, and total surface. Limited data associating the diabetic status with the expression of terminal placental differentiation markers are available. The human growth hormone/chorionic somatomammotropin (hGH/CS) family consists of five genes, one of which (GH-N) is expressed efficiently in pituitary while the other four (CS-A, B, L, and hGH-V) are expressed in placenta and represent ultimate placental differentiation markers. We developed and applied a sensitive RT-PCR method coupled with diagnostic restriction digestion to determine the relative levels of the hGH/CS family in normal pregnancies and examine whether their mRNA expression pattern is altered in pregnancies complicated by diabetes. We show that relative hCS-L content changes during placental development. Specifically, normal term placentas express higher relative levels of hCS-L, lower relative hGH-V levels and a 70-fold lower hGH-V/CS-L mRNA ratio compared to early placentas. Also, many term placentas from diabetic pregnancies express lower relative levels of hCS-L mRNA and a much higher hGH-V/CS-L mRNA ratio compared to normal term placenta, resembling more an early placenta pattern of expression. Thus, our study suggests that the expression of terminal placental differentiation markers, such as the hGH/CS genes, is altered in term placentas from these diabetics reflecting either impaired placental differentiation or post-differentiation impairment of normal placental function.
Hu
L
L
Department of Physiology, University of Manitoba, Winnipeg, Canada.
Lytras
A
A
Bock
M E
ME
Yuen
C K
CK
Dodd
J G
JG
Cattini
P A
PA
D016640:Diabetes, Gestational / Q000235:genetics*; D005260:Female; D014644:Genetic Variation; D005865:Gestational Age; D013006:Growth Hormone / Q000235:genetics*; D006801:Humans; D010920:Placenta / Q000737:chemistry; D010926:Placental Hormones / Q000235:genetics*; D010928:Placental Lactogen / Q000235:genetics*; D011247:Pregnancy; D012313:RNA / Q000096:biosynthesis; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors
C064980:GH2 protein, human; D010926:Placental Hormones; D012333:RNA, Messenger; D012313:RNA; D013006:Growth Hormone; D010928:Placental Lactogen